Sensitized cancer cells to cisplatin and Olaparib by inhibiting MCM8 in vitro and in vivo. Supressed tumor growth in HeLa (cervical cancer) and HCT116 (colon cancer). Here, MCM8 is linked to cervical carcinoma.